ReviewPLoS biology2009
Where do MAIT cells fit in the family of unconventional T cells?
Review in PLoS biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- MR1 blockade drives differential impact on integrative signatures based on circuits of circulating immune cells and soluble mediators in visceral leishmaniasis.Frontiers in immunology · 2024Article
- Where's the Beef? Understanding Allergic Responses to Red Meat in Alpha-Gal Syndrome.Journal of immunology (Baltimore, Md. : 1950) · 2022Review
- Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease.World journal of gastroenterology · 2021Review
- Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation.International journal of hematology · 2018Article
- Development of Asthma in Inner-City Children: Possible Roles of MAIT Cells and Variation in the Home Environment.Journal of immunology (Baltimore, Md. : 1950) · 2018Observational
- Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU).PloS one · 2018Article
- Article
- Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2017Article
- Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals.Mucosal immunology · 2017Article
- Continuous Dual Resetting of the Immune Repertoire as a Basic Principle of the Immune System Function.Journal of immunology research · 2017Review
- Innate Lymphoid Cells in HIV/SIV Infections.Frontiers in immunology · 2017Review
- Evolution of nonclassical MHC-dependent invariant T cells.Cellular and molecular life sciences : CMLS · 2014Review
- T cell recognition of non-peptidic antigens in infectious diseases.The Indian journal of medical research · 2013Review
- MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection.Proceedings of the National Academy of Sciences of the United States of America · 2013Article
- A 'GEM' of a cell.Nature immunology · 2013Article
- Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP.Blood · 2013Article
- Article
- Article
- Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor.The Journal of experimental medicine · 2012Article
- Presumed guilty: natural killer T cell defects and human disease.Nature reviews. Immunology · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.